Clinical & Translational Oncology

Papers
(The median citation count of Clinical & Translational Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level75
GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma51
Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma49
Immunotherapy in AML: a brief review on emerging strategies49
IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway39
Benefits of early salvage therapy on oncological outcomes in high-risk prostate cancer with persistent PSA after radical prostatectomy35
Long noncoding RNA MGC27382 inhibits proliferation and metastasis of non-small cell lung cancer cells via down-regulating AKT/GSK3β pathway34
microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway28
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus23
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis23
Mechanisms of regulating NIS transport to the cell membrane and redifferentiation therapy in thyroid cancer23
MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways22
Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling21
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group21
The TRIM proteins in cancer: from expression to emerging regulatory mechanisms20
Short-course radiotherapy in stage IV rectal cancer with resectable disease19
Circulating exosomal miRNAs and cancer early diagnosis17
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism16
MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway16
Physio-pathological effects of m6A modification and its potential contribution to melanoma15
The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database14
PD1/PDL1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors14
Stereotactic radiosurgery with immunotherapy is associated with improved overall survival in patients with metastatic melanoma or non-small cell lung cancer: a National Cancer Database analysis14
Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy14
Surgical resection of primary tumor in the extremities improves survival for metastatic soft-tissue sarcoma patients: a population-based study of the SEER database13
Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes13
COPB2: a transport protein with multifaceted roles in cancer development and progression13
Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-313
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients12
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for tre12
Isolated cancer stem cells from human liver cancer: morphological and functional characteristics in primary culture12
Correction to: The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database12
The effects of aerobic exercise on the intestinal tumors and flora of the ApcMin/+ mouse12
Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer12
A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics10
Long-term outcomes of spinal SBRT. Is it important to select the treatment time?10
In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types9
Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working Group9
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)9
Expressions of PD-L1 and Nectin-4 in urothelial cancer patients treated with pembrolizumab9
Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects9
Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy9
0.1262469291687